Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.diabres.2020.108162

http://scihub22266oqcxt.onion/10.1016/j.diabres.2020.108162
suck pdf from google scholar
32335097!7179491!32335097
unlimited free pdf from europmc32335097    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32335097      Diabetes+Res+Clin+Pract 2020 ; 163 (ä): 108162
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons? #MMPMID32335097
  • Pitocco D; Tartaglione L; Viti L; Di Leo M; Pontecorvi A; Caputo S
  • Diabetes Res Clin Pract 2020[May]; 163 (ä): 108162 PMID32335097show ga
  • Diabetes could be a risk factor for severity and mortality in patients with coronavirus disease 2019 COVID-19. It has been hypothesized that DPP4 inhibition, a therapy currently available for type 2 diabetes, might represent a target for decreasing the risk of the acute respiratory complications of the COVID-19 infection but (1) lack of demonstration of SARS-CoV2 binding to DPP4 (2) possible protective role of sDPP4 in Middle East respiratory Syndrome (MERS-CoV) (3) demonstrated inhibition and downregulation of DPP4 by HIV1 and MERS-CoV and (4) not exclusive role of the receptor binding in tropism of the Coronavirus family, support that DPP4 inhibition at present doesn't represent a plausible approach to mitigate COVID-19.
  • |COVID-19[MESH]
  • |Coronavirus Infections/*drug therapy[MESH]
  • |Diabetes Mellitus, Type 2/*drug therapy[MESH]
  • |Dipeptidyl Peptidase 4/*metabolism[MESH]
  • |Dipeptidyl-Peptidase IV Inhibitors/pharmacology/*therapeutic use[MESH]
  • |Humans[MESH]
  • |Hypoglycemic Agents/pharmacology/*therapeutic use[MESH]
  • |Pandemics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box